Fidanacogene elaparvovec
id:
fidanacogene-elaparvovec-183-19000196
title:
Fidanacogene elaparvovec
text:
Fidanacogene elaparvovec, sold under the brand name Beqvez among others, is a gene therapy delivered via adeno-associated virus used for the treatment of hemophilia B. Fidanacogene elaparvovec was approved for medical use in Canada in December 2023, in the United States in April 2024, and in the European Union in July 2024.
brand slug:
wiki
category slug:
encyclopedia
description:
Gene therapy
original url:
https://en.wikipedia.org/wiki/Fidanacogene_elaparvovec
date created:
2023-12-08T09:49:06Z
date modified:
2024-09-07T06:19:14Z
main entity:
{"identifier":"Q123982795","url":"https://www.wikidata.org/entity/Q123982795"}
image:
fields total:
13
integrity:
15